DENTSPLY SIRONA (XRAY) – Investment Analysts’ Weekly Ratings Changes

DENTSPLY SIRONA (NASDAQ: XRAY) has recently received a number of price target changes and ratings updates:

• 11/8/2024 – DENTSPLY SIRONA had its price target lowered by analysts at Barrington Research from $36.00 to $24.00. They now have an “outperform” rating on the stock.
• 11/8/2024 – DENTSPLY SIRONA had its price target lowered by analysts at Robert W. Baird from $31.00 to $24.00. They now have a “neutral” rating on the stock.
• 11/7/2024 – DENTSPLY SIRONA was downgraded by analysts at Leerink Partners from an “outperform” rating to a “market perform” rating.
• 11/7/2024 – DENTSPLY SIRONA was downgraded by analysts at Leerink Partnrs from a “strong-buy” rating to a “hold” rating.
• 11/6/2024 – DENTSPLY SIRONA was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 10/28/2024 – DENTSPLY SIRONA was upgraded by analysts at StockNews.com from a “hold” rating to a “buy” rating.
• 10/25/2024 – DENTSPLY SIRONA had its price target lowered by analysts at Needham & Company LLC from $34.00 to $29.00. They now have a “buy” rating on the stock.
• 10/8/2024 – DENTSPLY SIRONA had its price target lowered by analysts at Evercore ISI from $29.00 to $27.00. They now have an “outperform” rating on the stock.
• 9/20/2024 – DENTSPLY SIRONA had its “outperform” rating reaffirmed by analysts at Barrington Research. They now have a $36.00 price target on the stock.

DENTSPLY SIRONA Price Performance

Shares of XRAY opened at $17.35 on Thursday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company’s fifty day simple moving average is $24.21 and its 200 day simple moving average is $25.59. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60. The company has a market cap of $3.45 billion, a price-to-earnings ratio of -8.38, a PEG ratio of 1.75 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to analysts’ expectations of $939.10 million. During the same period in the prior year, the firm earned $0.49 EPS. DENTSPLY SIRONA’s quarterly revenue was up .4% compared to the same quarter last year. On average, research analysts forecast that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current fiscal year.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of large investors have recently added to or reduced their stakes in the business. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the last quarter. Capital Performance Advisors LLP acquired a new position in DENTSPLY SIRONA in the 3rd quarter valued at about $27,000. LRI Investments LLC raised its holdings in DENTSPLY SIRONA by 82.7% in the 2nd quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after acquiring an additional 564 shares during the period. Rothschild Investment LLC acquired a new stake in DENTSPLY SIRONA during the second quarter worth approximately $32,000. Finally, Kennebec Savings Bank bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth approximately $35,000. Institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.